Alpha 2.0
Login Register
» Articles » PMID: 39865241

Cardiovascular Disease Essential Medicines Listing by Countries: Changes over Time and Association with Health Outcomes

Overview
Journal BMC Cardiovasc Disord
Publisher Biomed Central
Date 2025 Jan 26
PMID 39865241
Authors
Camila Heredia
Moizza Zia Ul Haq
Adelaide Buadu
Amal Rizvi
Aine Workentin
Navindra Persaud
Affiliations
Soon will be listed here.
Abstract

Background: Since national essential medicine lists guide the procurement of medicines for populations in many countries, and cardiovascular diseases are the leading cause of death globally, including cardiovascular medicines on these lists can significantly impact healthcare outcomes.

Methods: In this cross-sectional study, national essential medicines' lists from 158 countries were analysed on whether or not they included medicines to treat ischemic heart disease, cerebrovascular disease, and hypertensive heart disease. A linear regression model was used to evaluate the association between countries' coverage scores and amenable mortality.

Results: Listing of cardiovascular disease treatment was associated with amenable mortality from hypertensive heart disease. Health expenditure per capita was also associated with amendable mortality due to ischemic heart disease, and hypertensive heart disease.

Conclusions: Listing essential medicines for cardiovascular disease is an important aspect of healthcare quality that is associated with cardiovascular mortality.

References
1.
Langhorne P, ODonnell M, Chin S, Zhang H, Xavier D, Avezum A . Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. Lancet. 2018; 391(10134):2019-2027. DOI: 10.1016/S0140-6736(18)30802-X. View
2.
. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Glob Health. 2022; 10(12):e1715-e1743. PMC: 9666426. DOI: 10.1016/S2214-109X(22)00429-6. View
3.
Persaud N, Jiang M, Shaikh R, Bali A, Oronsaye E, Woods H . Comparison of essential medicines lists in 137 countries. Bull World Health Organ. 2019; 97(6):394-404C. PMC: 6560372. DOI: 10.2471/BLT.18.222448. View
4.
Geldsetzer P, Manne-Goehler J, Marcus M, Ebert C, Zhumadilov Z, Wesseh C . The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet. 2019; 394(10199):652-662. DOI: 10.1016/S0140-6736(19)30955-9. View
5.
Sudharsanan N, Theilmann M, Kirschbaum T, Manne-Goehler J, Azadnajafabad S, Bovet P . Variation in the Proportion of Adults in Need of Blood Pressure-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1 037 215 Individuals From 50 Nationally Representative Surveys. Circulation. 2021; 143(10):991-1001. PMC: 7940589. DOI: 10.1161/CIRCULATIONAHA.120.051620. View